Glomerular repair: Present status and future expectations

Contributions to Nephrology

Volumn 169, Issue , 2011, Pages 351-362

  Herrera, Guillermo A ^a   Turbat Herrera, Elba A ^a   Teng, Jiamin ^a  

^a Nephrocor ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; APOPTOSIS; ARTICLE; BIOLOGICAL THERAPY; DISEASE COURSE; GLOMERULUS; HUMAN; KIDNEY DISEASE; MESENCHYMAL STEM CELL TRANSPLANTATION; NECROSIS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REGENERATION;

ANIMALS; APOPTOSIS; DISEASE PROGRESSION; HUMANS; KIDNEY DISEASES; KIDNEY GLOMERULUS; MESENCHYMAL STEM CELL TRANSPLANTATION; NECROSIS; REGENERATION; TISSUE THERAPY;

EID: 79551501354     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000315483     Document Type: Article

References (67)

1. De Vecchi AF, Dratwa M, Wiedemann ME: Healthcare systems and endstage renal disease (ESRD) therapies - an international review: costs and reimbursements/funding of ESRD therapies. Nephrol Dial Transplant 1999;14(Suppl 6):31-34.
2. Saxen L, Sariola H: Early organogenesis of the kidney. Pediatr Nephrol 1987;1:385-392.
3. Garcia- Sanchez O, Lopez- Hernandez FJ, Lopez- Novo JM: An integrative view on the role of TGF- β in the progressive tubular deletion associated with chronic renal disease. Kidney Int 2010;77:950-955.
4. Appel D, Kershaw D, Smeets B, Yuan G, Fuss A, Frye, B Elger, M Kriz, W Floege J, Moeller MJ: Derivation of podocytes from the parietal cell compartment. J Am Soc Nephrol 2009;20:333-343.
5. Sagrinati C, Netti GS, Mazzinghi B, Lazeri E, Liotta F, Frosali F, Ronconi E, Meini C, Gacci M, Squecco R, Carini M Gesualdo L, Francini F, Maggi E, Anunziato F, Lasagni L, Serio M, Romagnani S, Romagnani P: Isolation and characterization of multipotent progenitor cells from the Bowmans capsule of adult human kidneys. J Am Soc Nephrol 2006;17:2443-2456.
6. Ronconi E, Sagrinati C, Angelotti ML, Lazzer E, Mazzinghi B, Ballerini L, Prente E, Bechenucci F, Gacci M, Carini M, Maggi E, Serio M, Vannelli GB, Lasagni L, Romagnani S, Romagnani P: Regeneration of glomerular podocytes by human renal progenitors. J Am Soc Neprol 2009;20:322-332.
7. Border WA, Okuda S, Languino LR, Ruoslahti E: Transforming growth factor- β regulates production of proteoglycans by mesangial cells. Kidney Int 1990;37:689-695.
8. Yamamoto T, Noble NA, Miller DE, Border WA: Sustained expression of TGF- β underlies development of progressive kidney fibrosis. Kidney Int 1994;45:916-927.
9. Border WA, Noble NA: TGF- beta in kidney fibrosis: a target for gene therapy. Kidney Int 1987;51:1388-1396.
10. Tamaki K, Okuda S: Role of TGF- beta in the progression of renal fibrosis. Contrib Nephol 2003;139:44-65.
11. Zeisberg M, Hanai J, Sugimoto H, et al: BMP- 7 counteracts TGF- beta 1- induced epithelial to mesenchymal transition and reverses chronic renal injury. Nat Med 2003;9:964-968.
12. Wang S, de Caestecker M, Kopp J, Mitu G, LaPage, J, Hirschberg, R: Renal bone morphogenic protein- 7 protects against diabetic nephropathy. J Am Soc Nephrol 2006;17:2504-2512.
13. Zeisberg M, Kalluri R: Reversal of experimental renal fibrosis by BMP 7 provides insights into therapeutic strategies for chronic kidney disease. Pedriatr Nephrol 2008;23:1395-1398.
14. Herrero- Fresneda I, Torras J, Franquesa M, Vidal A, Cruzado JM, Loberas N, Fillat C, Grinyo JM: HGF gene therapy attenuates renal allograft scarring by preventing profibrotic inflammatory- induced mechanisms. Kidney Int 2006;70:265-274.
15. Yang J, Dai C, Liu Y: A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition. J Am Soc Nephrol 2005;16:68-78.
16. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E: Natural inhibitor of transforming growth factor- β protects against scarring in experimental kidney disease. Nature 2002;360:361-364.
17. Schaefer L, Macakova K, Raslik I, Mocegova M, Grone H- J, Schonherr E, Robenek H, Echtermeyer FG, Grassel S, Bruckner P, Schaefer RM, Iozzo R, Kresse H: Absence of decorin adversely influences tubulointerstitial fibrosis of the obstructed kidney by enhanced apoptosis and increased inflammatory reaction. Am J Pathol 2002;160:1181-1191.
18. Morel- Maroger SL, Killen PD, Chi E, Striker, GE: The composition of glomerulosclerosis: I. Studies in focal sclerosis, crescentic glomerulonephritis, and membranoproliferative glomerulonephritis. Lab Invest 1984;51:181-192.
19. Truong LD, Pundur J, Barrios R, DAgatti, V, Lechago J, Suki W, Majesky M: Tenascin is an important component of the extracellular matrix in normal and pathologic conditions. Kidney Int 1994;45:201-210.
20. Stetler- Stevenson WG: Dynamic of matrix turnover during pathologic remodeling of the extracellular matrix. Am J Pathol 1996;148:1345-1350.
21. El Nahas AM: Plasticity of mesangial cells: role in kidney remodeling and scarring. Kidney Int 2003;64:1553-1563.
22. Herrera GA: Plasticity of mesangial cells: a basis for understanding pathological alterations. Ultrastruct Pathol 2006;30:471-479.
23. Schlondorff DO: Overview of factors contributing to the pathophysiology of progressive renal disease. Kidney Int 2008;74:860-866.
24. Nath KA: Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 1992;20:1-17.
25. Bryder D, Rossi DJ, Weissman IL: Hematopoeitic stem cells. The paradigm tissue- specific stem cell. Am J Pathol 2006;169:338-346.
26. Al- Awqati Q, Oliver JA: Stem cells in the kidney. Kidney Int 2002;61:387-395.
27. Asnaghi V, Ferrari G, Rastaldi MP, Gabellini D, DellAntonio G, Maestroni A, Rugglieri D, Luzi L, Piemonti L, Zerbini G: Bone marrowderived stem cells repopulate glomerular and tubular kidney components. Effects of hyperglycemia (abstract). J Am Soc Nephrol 2004;15:29.
28. Chen J, Park H- C, Addabbo F, Ni J, Pelger E, Li H, Plotkin M, Goligorsky MS: Kidney- derived mesenchymal stem cells contribute to vasculogenesis, angiogenesis, and endothelial repair. Kidney Int 2008;74:879-889.
29. Kunter U, Rong S, Djuric Z, Boor P, Muller- Newen G, Yu D, Floege J: Transplanted mesenchymal cells accelerate glomerular healing in experimental glomerulonephritis. J Am Soc Nephrol 2006;17:2202-2212.
30. Caplan A: Why are MSCs therapeutic? New data: new insight. J Pathol 2009;217:318-324.
31. Chapel A, Bertho JM, Bensidhoum M, et al: Mesenchymal stem cells home to injured tissues when co- infused with hematopoietic cells to treat a radiation- induced multi- organ failure system. J Gene Med 2003;5:1028-1038.
32. Poulsom R, Alison MR, Cook T, Jeffery R, Ryan E, Forbes SJ, Hunt T, Wyles S, Wright NA: Bone marrow stem cells contribute to healing of the kidney. J Am Soc Nephrol 2003;14:S48-S54.
33. Zerbini G, Piemonti L, Maestroni A, Dell Antonio G, Bianchi G: Stem cells and the kidney: a new therapeutic tool? J Am Soc Nephrol 2006;17:S123-S126.
34. LeBleu V, Sugimoto H, Mundel TM, Gerami- Naini B, Finan E, Miller CA, Gattone VH, Lu L, Shield CF, Folkman J, Kalluri R: Stem cell therapies benefit Alports syndrome. J Am Soc Nephrol 2009;20:2359-2370.
35. Imasawa T, Nagasawa R, Utsunomiya Y, Kawamura T, Zhong Y, Makita N, et al: Bone marrow trans plantation attenuated murine IgA nephropathy: role of a stem cell disorder. Kidney Int 1999;56:1809-1817.
36. Ninichuk V, Gross O, Segerer S, Hoffman R, Radomska E, Buchstaller A, Huss R, Akis N, Schlondorff D, Anders H- J: Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic renal disease in collagen 4A3- deficient mice. Kidney Int 2006;70:121-129.
37. Morigi M, Imberti B, Zoja C, Corna D, Tomasoni S, Abate M, Rottoli D, Angioletti S, Benigni A, Perico N, Alison M, Remuzzi G: Mesenchymal stem cells are renotropic: helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol 2004;15:1794-1804.
38. Little M, Bertram JF: Is there such a thing as a renal stem cell? J Am Soc Nephrol 2009;20:2112-2117.
39. Humphreys BD: Slow- cycling cells in renal papilla: Stem cells awaken? J Am Soc Nephrol 2009;20:2277-2279.
40. Oliver JA, Kinakis FH, Friedlander J, Sampogna RV, Martens TP, Liu C, Efstratiadis A, Al- Awqati Q: Proliferation and migration of labelretaining cells of the kidney papilla. J Am Soc Nephrol 2009;20:2315-2327.
41. Ito T, Suzuki A, Imai E, Okabe M, Hori M: Bone marrow is a reservoir of repopulation mesangial cells during mesangial remodeling. J Am Soc Nephrol 2001;12:2625-2635.
42. Imai E, Ito T: Can bone marrow cells differentiate into renal cells?. Pediatr Nephrol 2002;17:790-794.
43. Ito T, Suzuki A, Okabe M, Imai E, Hori M: Application of bone marrowderived stem cells in experimental nephrology. Exp Nephrol 2001;9:444-450.
44. Poulsom R, Forbes SJ, Hodivala- Dilke K, Ryan E, Wyles S, Navaratnarasah S, Jeffery R, Hunt T, Alison M, Cook T, Pusey C, Wright NA: Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol 2001;195:229-235.
45. Gupta S, Verfaillie C, Chmielewski D, Krem S, Eidman K, Connaire J, Heremans Y, Lund T, Blackstad M, Jiang Y, Luttun A, Rosenberg M: Isolation and characterization of kidney- derived stem cells. J Am Soc Nephrol 2006;17:3028-3040.
46. Bussolati B, Bruno S, Grange C, Buttiglieri S, Deregibus MC, Cantino D, Camussi G: Isolation of renal progenitor cells from adult human kidney. Am J Pathol 2005;166:545-555.
47. Herrera MB, Bussolati B, Bruno S, Fonsato V, Romanazzi GM, Camussi G: Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med 2004;14:1035-1041.
48. Li J, Deane JA, Campanale NV, Bertram JF, Ricardo SD: The contribution of bone marrow- derived cells to the development of renal interstitial fibrosis. Stem Cells 2007;25:697-706.
49. Ross EA, Williams MJ, Hamazaki T, Terada N, Clapp WL, Adin C, Ellison GW, Jorgensen M, Batich CD: Embryonic stem cells proliferate and differentiate when seeded into kidney scaffolds. J Am Soc Nephrol 2009;20:2338-2347.
50. Maeshima A, Yamashita S, Nojima Y: Identification of renal progenitor- like tubular cells that participate in the regeneration processes of the kidney. J Am Soc Nephrol 2003;14:3138-3146.
51. Denkel B, Zngi L, Shezen E, Reich- Zeliger S, Eventov- Friedman S, Katchman H, Jacob- Hirsch J, Amariglio N, Rechavi G, Margalit R, Reisner Y: Isolation and characterization of nontubular sca- 1+linmultipotent stem/progenitor cells from adult mouse kidney. J Am Soc Nephrol 2006;17:3300-3314.
52. Kitamura S, Yamasaki Y, Kinomura M, Sugaya T, Sugiyama H, Maeschima Y, Makino H: Establishment and characterization of renal progenitor like cells from S3 segment of nephron in rat adult kidney. FASEB J 2005;19:1789-1797.
53. Wong CY, Cheong SK, Mok PL, Leong CF: Differentiation of human mesenchymal cells into mesangial cells in post- glomerular injury murine model. Pathology 2008;40:52-57.
54. Yokoo T, Ohashi T, Shen JS, Sakurai K, Miyasaki Y, Utsunomiya Y, et al: Human mesenchymal stem cells in rodent whole- embryo culture and reprogrammed to contribute to kidney tissues. Proc Nat Acad Sci USA 2005;102:3296-3300.
55. Teng J, Turbat- Herrera EA, Herrera GA: The role of translational research advancing the understanding of the pathogenesis of light chain (LC)- mediated glomerulopathies. Pathol Int 2007;57:398-412.
56. Keeling J, Teng J, Herrera GA: ALamyloidosis and light chain deposition disease light chains induce divergent phenotypic transformations of human mesangial cells. Lab Invest 2004;84:1322-1338.
57. Keeling J, Herrera GA: Matrix metalloproteinases and mesangial remodeling in light chain- related glomerular damage. Kidney Int 2005;68:1590-1603.
58. Keeling J, Herrera GA: An in vitro model of light chain deposition disease. Kidney Int 2009;75:634-645.
59. Herrera GA, Turbat- Herrera EA, Teng J: Repair of damaged mesangium by rat mesenchymal stem cells using a 6D living cell model (abstract). Amyloid 2010;17:44.
60. Teng J, Herrera GA: Replacement of injured rat mesenchymal mesangial cells by glomerulopathic light chains (GLCs) by rat mesenchymal cells (RMSCs): a 6D living cell model of mesangial repair (abstract). J Am Soc Nephrol 2008;19:435A.
61. Koh CJ, Atala A: Tissue engineering, stem cells, and cloning: opportunities for regenerative medicine. J Am Soc Nephrol 2004;15:1113-1125.
62. Rabelink TJ, van Kooten C: Stem cell therapy for glomerular disease. J Am Soc Nephrol 2006;17:2086-2088.
63. Zhu H, Mitsuhashi N, Klein A, Barsky LW, Weinberg K, Barr ML, Demetriou A, Wu GD: The role of hyaluronan CD44 in mesenchymal stem cell migration in the extracellular matrix. Stem Cells 2006;24:928-935.
64. Herrera MB, Bussolati B, Bruno S, Morando L, Mauriello- Romanazzi G, Sanavio F, Stamenkovic I, Biancone L, Camussi G: Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int 2007;72: 430-441.
65. Yakoo T, Kawamura T, Kobayash E: Stem cells for kidney repair: useful tool for acute renal failure. Kidney Int 2008;74:847-849.
66. Togel FE, Westenfelder C: Mesenchymal stem cells: a new therapeutic tool for AKI. Nephrol 2010;6:179-183.
67. Hopkins C, Li J, Rae F, Little MH: Stem cell options for kidney disease. J Pathol 2009;217:265-281.